E-Z-EM buys into virtual colonoscopy firm
This article was originally published in Clinica
Executive Summary
E-Z-EM, claimed to be the world's largest manufacturer of contrast agents for gastrointestinal radiology, has taken around 5% of the equity in privately-owned PointDx, whose software visualises the colon using CT imaging and 3D computer-aided reconstruction. In addition, E-Z-EM has a three-year option to acquire a further 120,000 shares and get a seat on the board.